Skip to main content

Table 2 Preoperative fine needle aspiration cytology and postoperative pathological features of patients

From: Identification of serum biomarker panel to differentiate malignant from benign thyroid nodules using multiplex bead assay

  BTN MTN Total
Preoperative FNAC
Bethesda (% risk of malignancy)/BTA II (0–3%)/Thy2 3 0 3
III (5–15%)/Thy3a 5 1 6
IV (15–30%)/Thy3f 12 6 18
V (60–75%)/Thy4 0 9 9
VI (97–99%)/Thy5 0 4 4
Total 20 20 40
Postoperative pathological diagnosis
Final diagnosis Colloid nodule 3 (15 %) 40
Adenomatous goiter 6 (30 %)
Follicular adenoma 11 (55 %)
PTC (including FVPTC) 17 (85%)
FTC 3 (15%)
Total 20 20
LN metastasis Positive 9 (45%)  
Negative 11 (55%)
Total   20
Vascular invasion Positive 3 (15%)  
Negative 17 (85%)
Total   20
  1. BTN benign thyroid nodule, MTN malignant thyroid nodule, FNAC fine needle aspiration cytology, LN lymph node, PTC papillary thyroid carcinoma, FTC follicular thyroid carcinoma, FVPTC follicular variant of papillary thyroid carcinoma